| Insideraktier | 478 504 883 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
null insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i TKMR / . Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
| Handelsdatum | Insider | Rapporterade aktier |
Rapporterat pris |
Justerade aktier |
Justerat pris |
Kostnadsbasis | Dagar til Max |
Pris vid Max |
Maximal vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | HENRIQUES RICHARD C JR | 1 000 | 6,9500 | 1 000 | 6,9500 | 6 950 | 24 | 7.56 | 610 | 8,78 |
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i TKMR / . Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 3 | Gline Matthew By Roivant Sciences Ltd. | ABUS | Common Shares | I | 38 847 462 | ||||||||
| 2025-02-19 | 2025-02-14 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 90 100 | 249 824 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 177 000 | 1 658 003 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 54 300 | 140 544 | ||||||
| 2025-02-19 | 2025-02-14 | 4 | Sims Karen | ABUS | Common Shares | D | 49 300 | 155 494 | ||||||
| 2025-02-05 | 2025-02-04 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 3,2830 | −11 333 | −37 | 86 244 | ||||
| 2025-02-05 | 2025-02-04 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 3,2830 | −23 790 | −78 | 1 481 003 | ||||
| 2025-02-05 | 2025-02-04 | 4 | Sims Karen | ABUS | Common Shares | D | 3,2830 | −19 348 | −64 | 106 194 | ||||
| 2025-02-05 | 2025-02-04 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 3,2830 | −22 183 | −73 | 159 724 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 3,6895 | −8 846 | −33 | 46 069 | ||||
| 2024-08-16 | 2024-08-14 | 4 | MANCHESTER KEITH S | ABUS | Common Shares | D | 0,5600 | 54 915 | 31 | 54 915 | ||||
| 2024-02-05 | 2024-02-02 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 2,3125 | −9 593 | −22 | 181 907 | ||||
| 2024-02-05 | 2024-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 112 500 | 191 500 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sims Karen | ABUS | Common Shares | D | 2,3125 | −4 358 | −10 | 125 542 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sims Karen | ABUS | Common Shares | D | 101 000 | 129 900 | ||||||
| 2024-02-05 | 2024-02-01 | 4 | Naftzger J. Christopher | ABUS | Common Shares | D | 95 100 | 95 100 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 2,3125 | −10 164 | −24 | 1 504 793 | ||||
| 2024-02-05 | 2024-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 123 800 | 1 514 957 | ||||||
| 2024-02-05 | 2024-02-02 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 2,3125 | −9 982 | −23 | 1 485 121 | ||||
| 2024-02-05 | 2024-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 109 500 | 1 495 103 | ||||||
| 2023-07-12 | 3 | Sims Karen | ABUS | Common Shares | D | 28 900 | ||||||||
| 2023-02-03 | 2023-02-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 82 200 | 1 385 603 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | McElhaugh Michael J. | ABUS | Common Shares | D | 83 700 | 1 391 157 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Collier William H. | ABUS | Common Shares | D | 216 500 | 216 500 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | HASTINGS DAVID C | ABUS | Common Shares | D | 79 000 | 79 000 | ||||||
| 2023-02-03 | 2023-02-01 | 4 | Howard Elizabeth | ABUS | Common Shares | D | 69 700 | 86 024 | ||||||
| 2022-05-26 | 2022-05-25 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Meyers James R | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | BURGESS DANIEL D | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-05-26 | 2022-05-25 | 4 | Torti Frank | ABUS | Stock Option (Right to Buy) | D | 2,25 | 41 000 | 41 000 | |||||
| 2022-01-20 | 2022-01-20 | 4 | Picchio Gaston | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 256 500 | 721 | 256 500 | |||
| 2022-01-20 | 2022-01-20 | 4 | Sofia Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285 000 | 801 | 285 000 | |||
| 2022-01-20 | 2022-01-20 | 4 | Howard Elizabeth | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 237 500 | 667 | 237 500 | |||
| 2022-01-20 | 2022-01-20 | 4 | HASTINGS DAVID C | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 285 000 | 801 | 285 000 | |||
| 2022-01-20 | 2022-01-20 | 4 | McElhaugh Michael J. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 325 850 | 916 | 325 850 | |||
| 2022-01-20 | 2022-01-20 | 4 | Collier William H. | ABUS | Stock Option (Right to Buy) | D | 2,81 | 2,8100 | 787 550 | 2 213 | 787 550 | |||
| 2021-12-03 | 2021-12-01 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 5,0900 | −200 000 | −1 018 | 1 303 403 | ||||
| 2021-11-12 | 2021-11-09 | 4 | Tran Tram | ABUS | Stock Option (Right to Buy) | D | 3,50 | 44 000 | 44 000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Series A participating convertible preferred shares | D | 7,13 | −1 164 000 | 0 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Roivant Sciences Ltd. | ABUS | Common shares, without par value | D | 22 833 922 | 38 847 462 | ||||||
| 2021-06-07 | 2021-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Meyers James R | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Torti Frank | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,95 | 22 000 | 22 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Picchio Gaston | ABUS | Stock Options | D | 4,33 | 250 000 | 250 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 4,33 | 250 000 | 250 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Collier William H. | ABUS | Stock Options | D | 4,33 | 675 000 | 675 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 4,33 | 200 000 | 200 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 4,33 | 249 000 | 249 000 | |||||
| 2021-02-17 | 2021-02-13 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 4,33 | 290 000 | 290 000 | |||||
| 2021-02-10 | 2021-02-09 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | −20 000 | −100 | 1 307 457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0032 | −10 000 | −50 | 1 327 457 | ||||
| 2020-12-16 | 2020-12-14 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0000 | −30 000 | −150 | 1 337 457 | ||||
| 2020-09-25 | 2020-09-23 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 70 000 | 70 000 | |||||
| 2020-09-25 | 2020-09-23 | 4 | Picchio Gaston | ABUS | Common Stock | D | 3,35 | 50 000 | 50 000 | |||||
| 2020-07-27 | 2020-07-23 | 4 | McElhaugh Michael J. | ABUS | Common Stock | D | 5,0100 | −20 000 | −100 | 1 367 457 | ||||
| 2020-06-01 | 2020-05-28 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 262 313 | 262 313 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Meyers James R | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Cheng Andrew | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Torti Frank | ABUS | Stock Options | D | 2,16 | 22 000 | 22 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | McElhaugh Michael J. | ABUS | Stock Options | D | 3,35 | 200 000 | 200 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | HASTINGS DAVID C | ABUS | Stock Options | D | 3,35 | 100 000 | 100 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Collier William H. | ABUS | Stock Options | D | 3,35 | 367 087 | 367 087 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Picchio Gaston | ABUS | Stock Options | D | 3,35 | 150 000 | 150 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Sofia Michael J. | ABUS | Stock Options | D | 3,35 | 250 000 | 250 000 | |||||
| 2020-02-19 | 2020-02-17 | 4 | Howard Elizabeth | ABUS | Stock Options | D | 3,35 | 79 500 | 79 500 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Torti Frank | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | MANCHESTER KEITH S | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Meyers James R | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | BURGESS DANIEL D | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | POTTER MYRTLE S | ABUS | Stock Options | D | 1,50 | 22 000 | 22 000 | |||||
| 2019-08-20 | 2019-08-17 | 4 | Cheng Andrew | ABUS | Stock Options | D | 1,50 | 60 000 | 60 000 | |||||
| 2019-06-26 | 2019-06-24 | 4 | Collier William H. | ABUS | Employee Stock Option (Right to Buy) | D | 2,18 | 1 112 000 | 1 112 000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 357 500 | 357 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | McElhaugh Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 104 500 | 104 500 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 145 000 | 145 000 | |||||
| 2019-03-05 | 2019-03-01 | 4 | Picchio Gaston | ABUS | Employee Stock Option (Right to Buy) | D | 4,57 | 137 500 | 137 500 | |||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-21 | 3 | McElhaugh Michael J. | ABUS | Common Shares | D | 2 774 914 | ||||||||
| 2018-12-13 | 2018-12-11 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 4,44 | 7 500 | 7 500 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 1,35 | −25 000 | 0 | |||||
| 2018-11-30 | 2018-11-28 | 4 | Murray Mark J. | ABUS | Common Shares | D | 1,3500 | 25 000 | 34 | 341 396 | ||||
| 2018-11-27 | 2018-11-26 | 4 | Torti Frank | ABUS | Director Share Option (right to buy) | D | 4,72 | 44 000 | 44 000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | POTTER MYRTLE S | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44 000 | 44 000 | |||||
| 2018-10-22 | 2018-10-18 | 4 | Meyers James R | ABUS | Director Share Option (Right to Buy) | D | 4,71 | 44 000 | 44 000 | |||||
| 2018-10-10 | 2018-10-08 | 4 | Picchio Gaston | ABUS | Employee Share Option (Right to Buy) | D | 9,38 | 200 000 | 200 000 | |||||
| 2018-08-15 | 2018-08-13 | 4/A | Sofia Michael J. Held by Irrrevocable Trust of Michael J. Sofia dated December 22, 2014 | ABUS | Common Shares | I | 9,5143 | −4 250 | −40 | 167 162 | ||||
| 2018-08-14 | 2018-08-13 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 9,5143 | −4 250 | −40 | 1 499 153 | ||||
| 2018-07-13 | 2018-07-11 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 10,0000 | −10 000 | −100 | 1 503 403 | ||||
| 2018-07-10 | 2018-07-09 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,9060 | −10 000 | −89 | 1 513 403 | ||||
| 2018-07-10 | 2018-07-06 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4500 | −10 000 | −84 | 1 523 403 | ||||
| 2018-07-06 | 2018-07-05 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,4000 | −10 000 | −84 | 1 533 403 | ||||
| 2018-07-06 | 2018-07-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | −10 000 | −80 | 1 543 403 | ||||
| 2018-06-25 | 2018-06-19 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | MANCHESTER KEITH S | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | Ramaswamy Vivek | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-22 | 2018-06-19 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 6,75 | 22 000 | 22 000 | |||||
| 2018-06-21 | 2018-06-19 | 4 | HASTINGS DAVID C | ABUS | Employee Stock Option (Right to Buy) | D | 6,75 | 200 000 | 200 000 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 160 000 | 160 000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | VandenEnden Koert | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 25 000 | 25 000 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | −27 007 | 0 | |||||
| 2018-04-17 | 2018-04-17 | 4 | Murray Mark J. | ABUS | Common Shares | D | 0,3540 | 27 007 | 10 | 316 396 | ||||
| 2018-04-17 | 2018-04-16 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 418 187 | 418 187 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 150 000 | 150 000 | |||||
| 2018-04-17 | 2018-04-16 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 5,20 | 30 000 | 30 000 | |||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5 500 | ||||||||
| 2018-02-22 | 3 | VandenEnden Koert | ABUS | Common Shares | D | 5 500 | ||||||||
| 2018-01-16 | 2018-01-12 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Lo Andrew | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Machado Patrick See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2018-01-16 | 2018-01-12 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 664 000 | 66 400 | 1 164 000 | |||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2017-10-18 | 3 | Dexcel Pharma Technologies Ltd. See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2017-10-18 | 2017-10-16 | 4 | Dexxon Holdings Ltd. See footnotes 3 and 4 | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | QVT Associates GP LLC | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | SVF Investments (UK) Ltd See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Lo Andrew See footnotes | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Roivant Sciences Ltd. | ABUS | Series A Participating Convertible Preferred Shares | D | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-17 | 2017-10-16 | 4 | Machado Patrick | ABUS | Series A Participating Convertible Preferred Shares | I | 7,13 | 100,0000 | 500 000 | 50 000 | 500 000 | |||
| 2017-10-05 | 2017-10-03 | 4 | Sofia Michael J. | ABUS | Common Shares | D | 8,0000 | −10 000 | −80 | 1 553 403 | ||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,6750 | −20 000 | −74 | 171 412 | ||||
| 2017-08-17 | 2017-08-15 | 4 | Sofia Michael J. Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 23, 2014 (the "Trust"). | ABUS | Common Shares | I | 3,7500 | −10 000 | −38 | 191 412 | ||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2017-06-23 | 2017-06-21 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-23 | 2017-06-21 | 4 | Ramaswamy Vivek | ABUS | Stock Option (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-06-22 | 2017-06-21 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option Grant (Right to Buy) | D | 3,55 | 22 000 | 22 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125 000 | 125 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 450 000 | 450 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 150 000 | 150 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Symonds William T. | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 50 000 | 50 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 200 000 | 200 000 | |||||
| 2017-04-05 | 2017-03-24 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,15 | 125 000 | 125 000 | |||||
| 2017-03-27 | 2017-03-24 | 4 | BURGESS DANIEL D | ABUS | Director Stock Option (Right to Buy) | D | 3,15 | 50 000 | 50 000 | |||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-10-19 | 3 | Machado Patrick See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 13 503 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 0,35 | 675 | 0 | |||||
| 2016-08-18 | 2016-08-16 | 4 | Abrams Michael J. | ABUS | Common Shares | D | 0,3455 | 14 178 | 5 | 42 097 | ||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Viking Long Fund GP LLC See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Sundheim Daniel S. See Explanation of Responses | ABUS | Common Shares | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Lo Andrew See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | Oren Dan See footnote. | ABUS | Common Shares, no par value | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-07-13 | 3 | QVT Fund V LP | ABUS | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Warrants | D | 2,57 | −5 000 | 0 | |||||
| 2016-06-20 | 2016-06-16 | 4 | Murray Mark J. | ABUS | Common Shares | D | 2,5688 | 5 000 | 13 | 289 389 | ||||
| 2016-06-07 | 2016-06-03 | 4 | KARBE FRANK | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | CONRAD HERBERT J | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | HENRIQUES RICHARD C JR | ABUS | Director Stock Option (Right to Buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-06-07 | 2016-06-03 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 3,99 | 7 500 | 7 500 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 50 000 | 50 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Cousins Bruce | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 145 000 | 145 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Kowalski Mark | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 85 000 | 85 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Lutwyche Peter | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 60 000 | 60 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Murray Mark J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 450 000 | 450 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Symonds William T. | ABUS | Executive Stock Option (Right to Buy) | D | 3,94 | 25 000 | 25 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Sofia Michael J. | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 100 000 | 100 000 | |||||
| 2016-03-17 | 2016-03-15 | 4 | Howard Elizabeth | ABUS | Employee Stock Option (Right to Buy) | D | 3,94 | 120 000 | 120 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35 000 | 35 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75 000 | 75 000 | |||||
| 2016-01-06 | 2015-07-09 | 4/A | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100 000 | 100 000 | |||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77 516 | ||||||||
| 2015-12-22 | 3 | Lutwyche Peter | ABUS | Common Shares | D | 77 516 | ||||||||
| 2015-12-22 | 2015-07-09 | 4 | Murray Mark J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 100 000 | 100 000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Cousins Bruce | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 75 000 | 75 000 | |||||
| 2015-12-22 | 2015-07-09 | 4 | Abrams Michael J. | ABUS | Employee Stock Option (right to buy) | D | 17,57 | 35 000 | 35 000 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | −219 428 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Murray Mark J. | TKMR | Common Shares | D | 0,4444 | 219 428 | 98 | 284 389 | ||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Employee Stock Option (right to buy) | D | 0,44 | −17 044 | 0 | |||||
| 2015-09-15 | 2015-09-11 | 4 | Abrams Michael J. | TKMR | Common Shares | D | 0,4444 | 17 044 | 8 | 27 919 | ||||
| 2015-08-26 | 2015-08-24 | 4 | HENRIQUES RICHARD C JR | ABUS | Common Shares | D | 6,9500 | 1 000 | 7 | 1 000 | ||||
| 2015-08-14 | 2015-08-12 | 4 | Ramaswamy Vivek | ABUS | Stock Option (right to buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | KARBE FRANK | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | MANCHESTER KEITH S | ABUS | Stock Option (right to buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | CONRAD HERBERT J | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-08-14 | 2015-08-12 | 4 | HENRIQUES RICHARD C JR | ABUS | Stock Option (Right to Buy) | D | 9,11 | 7 500 | 7 500 | |||||
| 2015-04-08 | 2015-03-30 | 4 | HENRIQUES RICHARD C JR | TKMR | Stock Option (right to buy) | D | 17,57 | 15 000 | 15 000 | |||||
| 2015-04-07 | 2015-03-30 | 4 | CONRAD HERBERT J | TKMR | Stock Option (right to buy) | D | 17,57 | 15 000 | 15 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Abrams Michael J. | TKMR | Stock Option (right to buy) | D | 17,57 | 50 000 | 50 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Cousins Bruce | TKMR | Stock Option (right to buy) | D | 17,57 | 80 000 | 80 000 | |||||
| 2015-04-02 | 2015-03-30 | 4 | Murray Mark J. | TKMR | Stock Option (right to buy) | D | 17,57 | 180 000 | 180 000 | |||||
| 2015-03-16 | 3 | CONRAD HERBERT J | TKMR | Common Stock | D | 0 | ||||||||
| 2015-03-16 | 3 | MANCHESTER KEITH S | TKMR | Common Stock, no par value | I | 0 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3 328 218 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1 966 227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. By Trust | TKMR | Common Stock | I | 1 966 227 | ||||||||
| 2015-03-16 | 3 | Sofia Michael J. | TKMR | Common Stock | D | 3 328 218 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Roivant Sciences Ltd. | TKMR | Common Stock | D | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512 654 | ||||||||
| 2015-03-16 | 3 | Symonds William T. | TKMR | Common Stock | D | 512 654 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3 529 630 | ||||||||
| 2015-03-16 | 3 | Higgins Patrick T. | TKMR | Common Stock | D | 3 529 630 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32 081 995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16 123 370 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek By Corporation | TKMR | Common Stock | I | 32 081 995 | ||||||||
| 2015-03-16 | 3 | Ramaswamy Vivek | TKMR | Common Stock | D | 16 123 370 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | QVT Fund V LP | TKMR | Common shares, no par value ("Common Shares") | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2015-03-16 | 3 | Oren Dan | TKMR | Common Stock | I | 32 027 080 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38 000 | ||||||||
| 2014-12-31 | 3 | Brennan Paul A. | TKMR | Common Shares | D | 38 000 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21 750 | ||||||||
| 2014-12-31 | 3 | Abrams Michael J. | TKMR | Common Shares | D | 21 750 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129 922 | ||||||||
| 2014-12-31 | 3 | Murray Mark J. | TKMR | Common Shares | D | 129 922 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969 330 | ||||||||
| 2014-12-31 | 3 | Jewell Donald Gordon | TKMR | Common Shares | D | 969 330 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77 516 | ||||||||
| 2014-12-31 | 3 | Lutwyche Peter | TKMR | Common Shares | D | 77 516 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20 000 | ||||||||
| 2014-12-31 | 3 | Phillips Peggy V | TKMR | Common Shares | D | 20 000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10 000 | ||||||||
| 2014-12-31 | 3 | KARBE FRANK | TKMR | Common Shares | D | 10 000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25 000 | ||||||||
| 2014-12-31 | 3 | KISNER DANIEL L | TKMR | Common Shares | D | 25 000 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
